novartis europharm limited - asciminib hydrochloride - leukemie, myelogeen, chronisch, bcr-abl positief - antineoplastische middelen - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
Europese Unie -
Nederlands -
EMA (European Medicines Agency)